Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses

Area of Science:

• Immunology
• Molecular Biology
• Transgenic Models

Background:

• CD23 exists in transmembrane (mCD23) and soluble (sCD23) forms, involved in immune functions.
• Abnormal CD23 expression is linked to lymphoid cell pathologies.
• Understanding CD23's role in vivo requires studying its overexpression effects.

Purpose of the Study:

• To investigate the in vivo effects of mCD23 and sCD23 overexpression on lymphoid cell development and immune function.
• To determine if CD23 overexpression impacts B and T cell maturation and antibody production.

Main Methods:

• Generation of transgenic mice overexpressing either mCD23 or sCD23 under Thy-1 and Ig heavy chain enhancer control.
• Analysis of lymphoid cell populations in thymus, spleen, bone marrow, and lymph nodes.
• Assessment of serum IgE and IgG1 levels during experimental immune responses.
• In vitro IgE and IgG1 secretion assays using B cells from transgenic mice.

Main Results:

• mCD23 and sCD23 overexpression did not significantly alter lymphoid cell maturation or basal IgE/IgG1 levels.
• mCD23 transgenic mice showed impaired increases in serum polyclonal IgE and IgG1 levels in immune response models.
• In vitro, B cells from mCD23 mice secreted normal IgE and IgG1, suggesting intact T-B cell interactions.

Conclusions:

• mCD23 overexpression, but not sCD23, impairs specific antibody production in vivo.
• The findings suggest mCD23-expressing cells influence Ig production through mechanisms beyond direct T-B cell contact.
• Further research is needed to elucidate the precise role of mCD23 in regulating immune responses.